Viewing Study NCT06997094


Ignite Creation Date: 2025-12-25 @ 1:38 AM
Ignite Modification Date: 2026-02-01 @ 7:49 PM
Study NCT ID: NCT06997094
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-10-27
First Post: 2025-05-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer
Sponsor: Mayo Clinic
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Human Papillomavirus-Negative Neck Squamous Cell Carcinoma View
None Resectable Head and Neck Squamous Cell Carcinoma View
None Resectable Human Papillomavirus-Independent Head and Neck Mucosal Squamous Cell Carcinoma View
None HPV-Negative Squamous Cell Carcinoma View
None Resectable Head and Neck Squamous-cell Carcinoma View
Keywords: